MAPK3 and urinary bladder cancer: Studies in human urinary bladder cancer cells have also reported that total and phosphorylated Erk1/2 protein levels are reduced in a 17-AAG-dependent manner [38]; however, the levels of total Erk1/2 following 17-AAG treatment differed depending on the cell type or cell line [38–40].